Testosterone Administration To Men With Testosterone Deficiency Syndrome After External Beam Radiotherapy For Localized Prostate Cancer
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology; Cancer / Oncology
Article Date: 05 Sep 2008 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
UroToday.com - Dr. Alvaro Morales and associates from the Centre for Applied Urological Research, reported on the first study on testosterone deficiency syndrome (TDS) in men treated with radiotherapy for prostate cancer. Five men with clinically localized CaP were prospectively studied. The mean Gleason sum was 7 and mean PSA level before radiotherapy was 12.8ng/ml. The mean PSA before testosterone replacement therapy (TRT) was 0.3ng/ml.
All five men had symptoms of TDS and two chose intramuscular injections of testosterone, one oral replacement and two used transdermal patches. Testosterone levels before TRT were 5.3 and at last visit were 17.6. The duration of follow-up was 14.6 months. One man had a transitory PSA increase, but none had levels of >1.5ng/ml.
All patients had marked responses in the symptoms of TDS, four with decreased hot flashes, decreased fatigue and improved libido, and two reported improved erectile function. One man discontinued therapy due to headaches. Four men had an improvement in sexual interest, but none recovered satisfactory erectile function with testosterone alone. A phosphodiesterase-5 inhibitor was successful in three men. The best overall symptom improvements were in hot flashes and fatigue. This report is hypothesis-generating for larger studies to address this issue.
Morales A, Black AM, Emerson LE
BJU Int. 2008 Jul 29. Epub ahead of print.
doi:10.1111/j.1464-410X.2008.07882.x
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/120399.php>
APA
http://www.medicalnewstoday.com/releases/120399.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



